Filing Details
- Accession Number:
- 0001209191-23-036994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-14 16:00:26
- Reporting Period:
- 2023-06-12
- Accepted Time:
- 2023-06-14 16:00:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1260990 | Oncternal Therapeutics Inc. | ONCT | Pharmaceutical Preparations (2834) | 621715807 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1786754 | F. Gunnar Kaufmann | 12230 El Camino Real, Suite 230 San Diego CA 92130 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-06-12 | 25,000 | $0.35 | 91,726 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-06-14 | 3,000 | $0.36 | 94,726 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The reported price is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.3448 to $0.3500. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares purchased at each price within the range set forth above.